ANRO
NYSE · Pharmaceuticals
Alto Neuroscience Inc
$20.58
+0.39 (+1.93%)
Open$20.25
Previous Close$20.19
Day High$20.80
Day Low$19.98
52W High$20.91
52W Low$1.60
Volume—
Avg Volume274.2K
Market Cap605.79M
P/E Ratio—
EPS$-2.31
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+7.7% upside
Current
$20.58
$20.58
Target
$22.17
$22.17
$14.63
$22.17 avg
$27.87
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 112.34M | 107.15M | 117.41M |
| Net Income | 25.21M | 21.35M | 24.46M |
| Profit Margin | 22.4% | 19.9% | 20.8% |
| EBITDA | 29.11M | 29.85M | 33.13M |
| Free Cash Flow | 25.43M | 19.85M | 18.41M |
| Rev Growth | +16.8% | +14.3% | +23.4% |
| Debt/Equity | 0.26 | 0.26 | 0.26 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |